VR Logo

Novan Inc. (NOVN) download report


Healthcare | Biotechnology & Pharma Research

Novan Inc. (NOVN) Premium Coverage

52 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Novan, Inc., a pre-commercial nitric oxide-based pharmaceutical company, focuses on dermatology and anti-infective therapies.

IPO Date: 21-Sep-2016

Pres, CEO & Chairwoman: Ms. Paula Brown Stafford M.P.H.

CFO & Corp. Sec.: Mr. John M. Gay CPA

Listing: NASDAQ: NOVN

Country: United States

Headquarters: Durham, CA

Website: https://www.novan.com

Key Facts

Market cap: $48.95 Mln

Revenue (TTM): $4.07 Mln

Earnings (TTM): $-34.12 Mln

Cash: $35.49 Mln

Total Debt: $20.63 Mln

Insider's Holding: 5.73%

Liquidity: Low

52 Week range: $2.15 - 10.58

Shares outstanding: 21,281,600

8 Years Aggregate:

  • CFO: $-214.16 Mln
  • EBITDA: $-227.38 Mln
  • Net Profit: $-238.57 Mln

Stock Performance

Time Period Novan (NOVN) S&P BSE Sensex S&P Small-Cap 600
YTD-44.84-8.99-19.23
1 month-10.85-3.40-9.35
3 months-36.46-8.50-16.59
1 Year-77.500.89-17.36
3 Years-56.0010.415.90
5 Years-43.6311.435.77
10 Years--11.779.78
As on 30-Jun-2022
Year Novan (NOVN) S&P Small-Cap 600 S&P BSE Sensex
2021-48.7125.2721.99
2020-74.279.5715.75
2019280.7220.8614.38
2018-80.16-9.705.87
2017-84.3811.7327.91